Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTT vs TTT + Triamcinolone for Exudation in Choroidal Melanoma
NCT02379000Phase 4Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in retinal detachment, sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
retinal detachment
Beyond the preview
Go deeper on NCT02379000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379000.